Mechanisms of the protective action of diethyldithiocarbamate-iron complex on acute cardiac allograft rejection

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 284, Issue 5 53-5, 2003, Pages

  Pieper, Galen M ^a,b   Nilakantan, Vani ^a   Hilton, Gail ^a   Halligan, Nadine L N ^a   Felix, Christopher C ^a   Kampalath, Bal ^a   Khanna, Ashwani K ^a   Roza, Allan M ^a   Johnson, Christopher P ^a   Adams, Mark B ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b FREE RADICAL RESEARCH CENTER   (United States)

Author keywords

Activator protein 1; Electron paramagnetic resonance spectroscopy; Interferon ; Nitric oxide synthase; Nuclear factor B

Indexed keywords

DIETHYLDITHIOCARBAMIC ACID; DNA; FERROUS SULFATE; GAMMA INTERFERON; HEMOPROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR AP 1;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DNA BINDING; DRUG EFFECT; DRUG MECHANISM; ELECTRON SPIN RESONANCE; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HISTOPATHOLOGY; LONG TERM CARE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TREATMENT OUTCOME;

EID: 0037405775     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00913.2002     Document Type: Article

References (57)

1. Baeuerle PA and Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 12: 141-179, 1994.
2. ω-monomethyl-L-arginine inhibits nitric oxide production in murine cardiac allografts but does not affect graft rejection. Biochim Biophys Acta 1226: 225-231, 1994.
3. Cai B, Roy DK, Sciacca R, Michler RE, and Cannon PJ. Effects of immunosuppressive therapy on expression of inducible nitric oxide synthase (iNOS) during cardiac allograft rejection. Int J Cardiol 50: 243-251, 1995.
4. Connor JR, Manning PT, Settle SL, Moore WM, Jerome GM, Webber RK, Tjoeng FS, and Currie MG. Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase. Eur J Pharmacol 273: 15-24, 1995.
5. Cooper M, Lindholm P, Pieper G, Seibel R, Moore G, Nakanishi A, Dembny K, Komorowski R, Johnson C, Adams M, and Roza A. Myocardial nuclear factor-κB activity and nitric oxide production in rejecting cardiac allografts. Transplantation 66: 838-844, 1998.
6. Dickinson E, Tuncer R, Nadler E, Boyle P, Alber S, Watkins S, and Ford H. NOX, a novel nitric oxide scavenger, reduces bacterial translocation in rats after endotoxin challenge. Am J Physiol Gastrointest Liver Physiol 277: G1281-G1287, 1999.
7. Finco TS and Baldwin AS. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity 3: 263-272, 1995.
8. Giannoukakis N, Bonham CA, Qian S, Zhou Z, Peng L, Harnaha J, Li W, Thomson AW, Fung JJ, Robbins PD, and Lu L. Prolongation of cardiac allograft survival using dendritic cells treated with NF-κB decoy oligodeoxyribonucleotides. Mol Ther 1: 430-437, 2000.
9. Huang YC, Guh JH, Cheng ZJ, Chang YL, Hwang TL, Lin CN, and Teng CM. Inhibitory effect of DCDC on lipopolysaccharide-induced nitric oxide synthesis in RAW 264.7 cells. Life Sci 68: 2435-2447, 2001.
10. Kleinert H, Euchenhofer C, Ihrig-Biedert I, and Förstermann U. In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NF-κB. J Biol Chem 271:6039-6044, 1996.
11. Koglin J, Glysing-Jensen T, Mudgett JS, and Russell ME. NOS2 mediates opposing effects in models of acute and chronic cardiac rejection. Insights from NOS2 knockout mice. Am J Pathol 153: 1371-1376, 1998.
12. Kojima S, Kiyozumi M, Honda T, Senba Y, Kaminaka K, and Ohnishi M. Studies on poisonous metals. XVIII. Effects of several dithiocarbamates on tissue distribution and excretion of cadmium in rats. Chem Pharm Bull (Tokyo) 35: 3838-3844, 1987.
13. Komarov AM, Kramer JH, Mak IT, and Weglicki WB. EPR detection of endogenous nitric oxide in postischemic heart using lipid and aqueous-soluble dithiocarbamate-iron complexes. Mol Cell Biochem 175: 91-97, 1997.
14. Komarov A, Mattson D, Jones MM, Singh PK, and Lai CS. In vivo spin trapping of nitric oxide in mice. Biochem Biophys Res Commun 195: 1191-1198, 1993.
15. Kozlov AV, Sobhian B, Duvigneau C, Gemeiner M, Nohl H, Redl H, and Bahrami S. Organ specific formation of nitrosyl complexes under intestinal ischemia/reperfusion in rats involves NOS-independent mechanism(s). Shock 15: 366-371, 2001.
16. Lai CS and Komarov AM. Spin trapping of nitric oxide produced in vivo in septic shock mice. FEBS Lett 345: 120-124, 1994.
17. Lecour S, Maupoil V, Siri O, Tabard A, and Rochette L. Electron spin resonance detection of nitric oxide generation in major organs from LPS-treated rats. J Cardiovasc Pharmacol 33:78-85, 1995.
18. Lewis NP, Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leyen H, Trindade PT, Cooke JP, Hunt SA, Billingham ME, Valantine HA, and Fowler MB. Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 93: 720-729, 1996.
19. Liu J, Shigenaga MK, Yan LJ, Mori A, and Ames BN. Antioxidant activity of diethyldithiocarbamate. Free Radic Biol Med 24: 461-472, 1996.
20. Malinski T, Taha Z, Grunfeld S, Patton S, Kapturczak M, and Tomboulian P. Diffusion of nitric oxide in the aorta wall. Biochem Biophys Res Commun 193: 1076-1082, 1993.
21. Mankhekorn S, Abedinzdeh Z, and Houee-Levin C. Antioxidant action of sodium diethyldithiocarbamate: reaction with hydrogen peroxide and superoxide radical. Free Radic Biol Med 17:517-527, 1994.
22. Marks-Konczalik J, Chu SC, and Moss J. Cytokine-mediated transcriptional induction of the human inducible nitric oxide synthase gene requires both activator protein 1 and nuclear factor κB-binding sites. J Biol Chem 273: 22201-22208, 1998.
23. Menezes J, Hierholzer C, Watkins SC, Lyons V, Peitzman AB, Billiar TR, Tweardy DJ, and Harbrecht BG. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. Am J Physiol Gastrointest Liver Physiol 277: G144-G151, 1999.
24. 2 and antioxidants have opposite effects on activation of NF-κB and AP-1 in intact cells: AP-1 as a secondary antioxidant responsive factor. EMBO J 12: 2005-2015, 1993.
25. 2+ with diethyldithiocarbamate or N-methyl-D-glucamine dithiocarbamate traps of nitric oxide in animal tissues: comparative investigations. Biochim Biophys Acta 1336: 225-234, 1997.
26. Mora AL, Youn J, Keegan AD, and Boothby M. NF-κB/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells. J Immunol 166: 2218-2227, 2001.
27. Mordvintcev P, Mülsch A, Busse R, and Vanin A. On-line detection of nitric oxide formation in liquid aqueous phase by electron paramagnetic resonance spectroscopy. Anal Biochem 199:142-146, 1991.
28. Mülsch A, Schray-Utz B, Mordvintcev PI, Hauschildt S, and Busse R. Diethyldithiocarbamate inhibits induction of macrophage NO synthase. FEBS Lett 321: 215-218, 1993.
29. Paschenko SV, Khramtsov VV, Skatchkov MP, Plyusnin VF, and Bassenge E. EPR and laser flash photolysis studies of the reaction of nitric oxide with water soluble NO trap Fe(II)-proline-dithiocarbamate complex. Biochem Biophys Res Commun 225: 577-584, 1996.
30. Paul LC, Myllärniemi M, Muzaffar S, and Benediktsson H. Nitric oxide synthase inhibition is associated with decreased survival of cardiac allografts in the rat. Transplantation 62: 1193-1195, 1996.
31. Pepperl S, Dörger M, Ringel F, Kupatt C, and Krombach F. Hyperoxia upregulates the NO pathway in alveolar macrophages in vitro: role of AP-1 and NF-κB. Am J Physiol Lung Cell Mol Physiol 280: L905-L913, 2001.
32. Pieper GM, Adams MB, Felix CC, and Roza AM. Role of nitric oxide in cardiac transplant rejection: documentation by EPR spectroscopy and other techniques. In: Nitric Oxide: Basic Research and Clinical Applications, edited by Gryglewski RJ and Minuz P. Amsterdam: IOS, 2001, p. 71-79.
33. Pieper GM, Cooper M, Johnson CP, Adams MB, Felix CC, and Roza AM. Reduction of myocardial nitrosyl complex formation by a nitric oxide scavenger prolongs cardiac allograft survival. J Cardiovasc Pharmacol 35: 114-120, 2000.
34. Pieper GM, Roza AM, Adams MB, Hilton G, Johnson M, Felix CC, Kampalath B, Darkes M, Wanggui Y, Cameron B, and Fricker SP. A ruthenium (III) polyaminocarboxylate complex, a novel nitric oxide scavenger, enhances graft survival and decreases nitrosylated heme protein in models of acute and delayed cardiac transplant rejection. J Cardiovasc Pharmacol 39: 414-418, 2002.
35. + T lymphocytes. Toxicology 128: 83-90, 1998.
36. Reinke LA, Moore DR, and Kotake Y. Hepatic nitric oxide formation: spin trapping detection in biliary efflux. Anal Biochem 243: 8-14, 1996.
37. Roza AM, Cooper M, Pieper G, Hilton G, Dembny K, Lai CS, Lindholm P, Komorowski R, Felix C, Johnson C, and Adams M. NOX100, a nitric oxide scavenger, enhances cardiac allograft survival and promotes long-term graft acceptance. Transplantation 69: 227-231, 2000.
38. Schenk H, Klein M, Erdbrügger W, Dröge W, and Schulze-Osthoff K. Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NFκB and AP-1. Proc Natl Acad Sci USA 91: 1672-1676, 1994.
39. Sen CK and Packer L. Antioxidant and redox regulation of gene transcription. FASEB J 10: 709-720, 1996.
40. Shames BD, Meldrum DR, Selzman CH, Pulido EJ, Cain BS, Banerjee A, Harken AH, and Meng X. Increased levels of myocardial IκBα protein promote tolerance to endotoxin. Am J Physiol Heart Circ Physiol 275: H1084-H1091, 1998.
41. Sica A, Dorman L, Viggiano V, Cippitelli M, Ghosh P, Rice N, and Yound HA. Interaction of NF-κB and NFAT with interferon-γ promoter. J Biol Chem 272: 30412-30420, 1997.
42. G-monomethylarginine in vitro and in vivo. Eur J Pharmacol 294: 703-712, 1995.
43. Soto PF, Jia CX, Rabkin DG, Hart JP, Carter YM, Sardo MJ, Hsu DT, Fisher PE, Pinsky DJ, and Spotnitz HM. Improvement of rejection-induced diastolic abnormalities in rat cardiac allografts with inducible nitric oxide synthase inhibition. J Thorac Cardiovasc Surg 120: 39-46, 2000.
44. Suzuki Y, Fujii S, Tominaga T, Yoshimoto T, Yoshimura T, and Kamada H. The origin of an EPR signal observed in dithiocarbamate-loaded tissues. Copper (II)-dithiocarbamate complexes account for the narrow hyperfine lines. Biochim Biophys Acta 1335: 242-245, 1997.
45. Suzuki J, Morishita R, Amano J, Kaneda Y, and Isobe M. Decoy against nuclear factor-kappa B attenuates myocardial cell infiltration and arterial neointimal formation in murine cardiac allografts. Gene Ther 7: 1847-1852, 2000.
46. Szabolcs MJ, Ravalli S, Minanov O, Sciacca RR, Michler RE, and Cannon PJ. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 65: 804-812, 1998.
47. Tominaga T, Sato S, Ohnishi T, and Ohnishi ST. Potentiation of nitric oxide formation following bilateral carotid occlusion and focal cerebral ischemia in the rat: in vivo detection of the nitric oxide radical by electron paramagnetic resonance spin trapping. Brain Res 614: 342-346, 1993.
48. Vanin AF, Huisman A, Stroes ESG, De Ruijter-Heijstek FC, Rabelink TJ, and Van Faassen EE. Antioxidant capacity of mononitrosyl-iron-dithiocarbamate complexes: implications for NO trapping. Free Radic Biol Med 30: 813-824, 2001.
49. Vos IHC, Govers R, Gröne HJ, Kleij L, Schurink M, De Weger RA, Goldschmeding R, and Rabelink TJ. NFκB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. FASEB J 14: 815-822, 2000.
50. Wallis G, Brackett D, Lerner M, Kotake Y, Bolli R, and McCay PB. In vivo spin trapping of nitric oxide generated in the small intestine, liver and kidney during the development of endotoxemia: a time-course study. Shock 6: 274-278, 1996.
51. Winlaw DS, Schyvens CG, Smythe GA, Du ZY, Rainer SP, Lord RSA, Spratt PM, and Macdonald PS. Selective inhibition of nitric oxide production during cardiac allograft rejection causes a small increase in graft survival. Transplantation 60: 77-82, 1995.
52. Worrall NK, Lazenby WD, Misko TP, Lin TS, Rodi CP, Manning PT, Tilton RG, Williamson JR, and Ferguson TB Jr. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 181: 63-70, 1995.
53. Worrall NK, Misko TP, Sullivan PM, Hui JJ, and Ferguson TB Jr. Inhibition of inducible nitric oxide synthase attenuates established acute cardiac allograft rejection. Ann Thorac Surg 62:378-385, 1996.
54. Worrall NK, Misko TP, Sullivan PM, Hui JJ, Rodi CP, and Ferguson TB Jr. Corticosteroids inhibit expression of inducible nitric oxide synthase during acute cardiac allograft rejection. Transplantation 61: 325-328, 1996.
55. Yang X, Chowdhury N, Cai B, Brett J, Marboe C, Sciacca RR, Michler RE, and Cannon PJ. Induction of myocardial nitric oxide synthase by cardiac allograft rejection. J Clin Invest 94:714-721, 1994.
56. Zweier JL, Samouilov A, and Kuppusamy P. Non-enzymatic nitric oxide synthesis in biological systems. Biochim Biophys Acta 1411: 250-262, 1999.
57. Zweier JL, Wang P, and Kuppusamy P. Direct measurement of nitric oxide generation in the ischemic heart using electron paramagnetic resonance spectroscopy. J Biol Chem 270: 304-307, 1995.